Jim Cramer's Lightning Round: Shopify, CrowdStrike, Rubrik, and More Stock Picks

Stock Recommendations from Jim Cramer

• 💡 Affirm is considered undervalued, with its CEO Max Levchin described as a genius.
• ❓ Prime Medicine is a stock Cramer is stumped on, indicating a lack of clear conviction.
• 🚀 Rocket Lab is viewed as controversial and speculative, not a blue-chip stock, despite having a real business model.
• ⚠️ Beam Therapeutics is identified as a highly speculative stock that Cramer cannot recommend positively.
• 📉 Crown Castle is struggling due to a less-than-ideal yield and business model issues, particularly in urban areas.
• 📈 Philip Morris is acknowledged as a historically great performing stock, though Cramer has reservations about its products.
• 🛍️ Shopify is a stock Cramer likes, especially after its tie-up with ChatGPT, predicting it will go much higher.
• 🏢 CoreWeave is praised for its expertise in maintaining data centers, with a desire for a deal to go through to allow focus on growth.
• ✅ Rubrik receives a straightforward "buy" recommendation.
• 💻 Service Now is highly recommended as a software stock that can be recommended without hesitation.
• 💥 CrowdStrike is volatile, but Cramer believes in the CEO and sees the stock going higher, potentially much higher.